The investigation centers on allegations that The Ensign Group provided shareholders with materially misleading business information. Hunterbrook’s findings, released after a five-month inquiry, claim the company’s financial success relies on diverting taxpayer funds toward executives and affiliates while failing to provide adequate patient care. The report includes serious accusations regarding patient welfare and mortality linked to these operational practices.

Rosen Law Firm is currently organizing a class action to recover losses for affected investors. Shareholders who purchased securities during the period in question may participate through a contingency fee arrangement, which requires no out-of-pocket costs. Those interested in the litigation can contact Phillip Kim at 866-767-3653 or visit the firm's website to register for the proceedings.